Últimas noticias sobre Biomerica (NASDAQ:BMRA) Bolsa

Biomerica

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Equities

News

Markets

AAPL

BMRA

RIVN

TSLA

Mercados de EE.UU. bajan, con Apple, Tesla, Biomerica, Rivian y UnitedHealth destacando por movimientos clave en sus acciones.

Apple, Rivian, UnitedHealth, Biomerica, Tesla: 5 valores que están en el radar de los inversores

Biomerica Inc

Press Releases

General

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Legal

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Earnings

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Health Care

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Biomerica Reports Third Quarter Fiscal 2025 Financial Results

Biomerica Announces Reverse Stock Split

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Aethlon Medical

Autonomix Medical

Bluejay Diagnostics

BioSig Technologies

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

HeartSciences

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

NanoVibronix

NAYA Biosciences

NeuroMetrix

Nuwellis

PAVmed

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Venus Concept

Catheter Precision

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

WIIM

Biomerica shares are trading higher after the company announced its Fortel Kidney Disease Test has been approved for sale by the UAE Ministry of Health and Prevention.

Comments

Biomerica

Noticias

Últimas noticias sobre Biomerica (NASDAQ:BMRA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL